Skip to content

Talphera, Inc. TLPH Cash & Equivalents

Cash & Equivalents at other companies

Baxter International logo
Baxter InternationalBAX
$2.02B-12.1%
AMP
Amphastar PharmaceuticalsAMPH
$170.94M-6.5%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$130.89M-15.0%
Royalty Pharma logo
Royalty PharmaRPRX
$586.4M-46.1%
PTH
Pelthos Therapeutics Inc.PTHS
$31.98M+24,250%
XOMA Corporation logo
XOMA CorporationXOMA
$85.6M-5.2%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s cash & equivalents?
Talphera, Inc. (TLPH) reported cash & equivalents of $3.82M in Q1 2026.
How has Talphera, Inc.'s cash & equivalents changed year-over-year?
Talphera, Inc.'s cash & equivalents decreased by 29.0% year-over-year, from $5.39M to $3.82M.
What is the long-term trend for Talphera, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Talphera, Inc.'s cash & equivalents has grown at a -23.3% compound annual growth rate (CAGR), from $22.27M to $5.89M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.